1Henon PHR, Buttirini A, Gale RP. Blood-derived haematopoietc cell transplantation: blood to blood? Lancet, 1991, 337:961
2Matsuda Y, Hara J, Osugi Y, et al. Allogeneic peripheral stem cell transplantation using positively selected CD34+ cells from HLA mismatched donors. Bone Marrow Transplant, 1998,21:355
3曹世龙.肿瘤学科理论与新技术.上海:上海科技教育出版社,1997.724-725
4Pamela C, ad Lori JG. Peripheral blood stem cell transplant in breast cancer. Sem Oncol, 1995, 22(3): 238
5Levitt D.Hematopoietic Stem Cell:Biology and Therapeutic Applications. New York: Marcel Dekker Inc, 1995. 535-556
6Greenbeg PAC. Long-term follow-up of patients with complete remission following combination chemotherapy for metastatic breast cancer. J Clin Oncol, 1996, 14:2197
7Williams SF. High-dose consolidation therapy with autologous stem cells rescue in stage Ⅳ breast cancer: follow-up report. J Clin Oncol, 1992, 10:1743
8Wormann B.Early intensive and mycloanlative adjuvant chemotherapy in women with high-risk breast cancer. Anticancer Res,1998, 18(3c): 2237
9Antman Kh. High- dose chemotherapy with autolouous hemopoietic stem cell support for breast cancer in Northern American. J Clin Oncol, 1997, 15:1870
10Willians SF. Application of peripheral blood progentors to doseintensive therapy of breast cancer. Breast Cancer Res Treat, 1993,26:s25
